Adèle Bouyer reviews how a recent change in FDA regulation may herald a decline in animal testing, in the face of new alternative models.
Ilke Boran argues that there may be much to be gained from space exploration, as long as the benefits are made available to all.
Bella Cooper-Brown reviews a recent talk by researcher of nuclear energy systems Eugene Shwageraus, dispelling myths about nuclear energy.
Jessye Phillips argues we shouldn’t give in to simplistic views of genetic engineering – it has great potential to tackle climate change.
The COVID-19 pandemic thrust medical research into the global spotlight. It bridged established disconnects between scientists and the public, between science and industry, and within the scientific community itself. It demonstrated the power of researchers working collaboratively towards a common goal. And yet, the pandemic also fostered unprecedented levels of scientific competition.
Isabel Schmidt discusses GMO crops and the debate about their safety.
For years medications have been overprescribed by doctors, costing millions and harming the environment. Amy Booth discusses how green social prescribing may be the answer to reduce these costs and help support people with nature-based interventions.